Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$16.89 - $35.01 $1,689 - $3,501
-100 Reduced 9.09%
1,000 $9,000
Q2 2023

Jul 18, 2023

SELL
$13.29 - $18.01 $268,458 - $363,802
-20,200 Reduced 94.84%
1,100 $0
Q1 2023

May 01, 2023

BUY
$7.17 - $18.55 $152,721 - $395,115
21,300 New
21,300 $3,000
Q3 2022

Oct 25, 2022

BUY
$7.94 - $12.36 $7,940 - $12,360
1,000 Added 100.0%
2,000 $1,000
Q2 2022

Aug 04, 2022

SELL
$5.21 - $12.14 $79,713 - $185,742
-15,300 Reduced 93.87%
1,000 $1,000
Q1 2022

Apr 14, 2022

SELL
$7.34 - $17.16 $853,642 - $2 Million
-116,300 Reduced 87.71%
16,300 $137,000
Q4 2021

Jan 18, 2022

BUY
$11.38 - $53.41 $1.48 Million - $6.96 Million
130,400 Added 5927.27%
132,600 $771,000
Q1 2021

Apr 26, 2021

SELL
$55.47 - $72.35 $432,666 - $564,330
-7,800 Reduced 78.0%
2,200 $1,000
Q1 2020

May 07, 2020

BUY
$16.11 - $36.23 $161,100 - $362,299
10,000 New
10,000 $53,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.08B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.